Medical device products supplier Navtar’s new facility is backed by a $15 million investment to support the growing needs of the Asia-Pacific pharmaceutical and medical device markets, as well as provide a secondary supply source for other regions.
Microextrusion tubing has been developed in recent years to service a variety of demanding neurovascular interventional therapies and surgical applications. Natvar’s new microextrusion medical tubing can be made from cost-effective thermoplastics and other highly-engineered materials. Because it can consistently hold tight tolerances, it is an ideal alternative to more expensive materials such as glass and fluoropolymers.
Natvar’s technical expertise enables it to microextrude monolayer, coextruded, multi-lumen tubing or profiles in a variety of thermoplastic (PVC, urethanes, TPEs) materials and wall thicknesses ranging from .003 to .005 in. It can be coextruded in up to four layers.
The company also announces the global availability of its high-precision medical silicone extrusion tubing, typically used for catheters, feeding tubes, drug delivery and peristaltic pump applications.
Natvar’s latest investment in expanded silicone extrusion capacity helps provide a one-stop global solution for complex medical applications and supports the growing need for biological compatibility for implantable medical devices.
